4//SEC Filing
Singh Shawn 4
Accession 0001415889-21-002139
CIK 0001411685other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 4:13 PM ET
Size
7.4 KB
Accession
0001415889-21-002139
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-04-23−5,000→ 0 totalExercise: $1.50From: 2018-08-29Exp: 2021-04-26→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-04-23$1.50/sh+5,000$7,500→ 40,375 total
Holdings
- 26,234(indirect: By Trust)
Common Stock
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001412071
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 4:13 PM ET
- Size
- 7.4 KB